首页 > 市场调查报告书 > 医疗设备

心血管设备

市场调查报告书

商品编码

1289775

全球心脏病发作诊断市场 - 2023-2030年

Global Heart Attack Diagnostics Market - 2023-2030

出版日期: 2023年06月12日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球心脏病诊断市场在2022年达到87.446亿美元，预计到2030年将见证有利可图的增长，达到156.053亿美元。在预测期间（2023-2030年），全球心脏病诊断市场预计将呈现7.7%的复合年增长率。

全球心脏病诊断市场受到许多变量的影响，包括饮食习惯、环境暴露和遗传易感性。这些因素可以通过引起高血压、高胆固醇、肥胖和糖尿病而增加心血管疾病的风险。

心脏病发作也在很大程度上受到不健康习惯的影响，包括吸烟、喝太多的酒和吃很多快餐。由于采用了这些有害的习惯，人口中心脏病发作的流行率增加。

市场动态

采用新产品发布中使用的重要措施

心脏病发作诊断法市场的扩张正受到各种因素的推动，包括医疗保健支出的增加，领先企业之间的伙伴关系和合作，以及研发的增加。

例如，2022年11月，美国最大的虚拟第一心血管公司Heartbeat Health和开发心脏疾病新护理标准的初创公司Cleerly宣布合作，采用精准的心脏健康，更精确地评估心血管风险，提供更好的心脏护理。由于Cleerly的人工智能分析冠状动脉计算机断层扫描（CCTA）的方法，医生可以更快识别、描述和测量心脏动脉壁的动脉粥样硬化（斑块堆积）。

此外，在2022年11月，CardioSignal和OMRON Healthcare（一家制造和销售自动化部件、设备和系统的公司）联手，通过向医生提供早期心血管疾病检测方面的突破，为处于人口健康管理前沿的医生提供服务。

这两家企业将合作开发数字健康解决方案，以加强生活方式慢性病的工作流程，特别是对心血管疾病的初级护理识别。主要参与者的战略以这样的方式来推动市场的发展。

缺少熟练的劳动力将阻碍市场的发展

由于心导管手术是一项具有挑战性的治疗，需要高度的精确性和准确性，因此需要一个高度认证、熟练和有经验的医疗专家团队来进行有效的心导管手术。

预计在整个预测期内，市场的扩张将在一定程度上受到缺乏熟练的专家来进行冠状动脉造影的限制，特别是在新兴国家，由于缺乏全面的培训计划。

COVID-19影响分析

SARS-CoV-2病毒的流行导致了全球封锁，对心脏病的诊断产生了灾难性的影响。有心脏疾病的人更容易感染病毒，特别是那些容易发生心脏病的人，如果不能及早发现感染，他们很有可能会死亡。

此外，由于缺乏及时诊断，人们对心血管健康结果的长期恶化有很大担忧。在病人获得心血管诊断和治疗的过程中，并没有很多不同的参与方。

俄乌战争影响分析

由于俄罗斯-乌克兰在该地区没有关键的市场参与者，估计对全球心脏病诊断市场的影响很小。然而，在预测期内，原材料、测试产品和设备的进出口的影响预计对全球心脏病诊断市场的影响很小。

人工智能影响分析

人工智能预计将对全球心脏病诊断市场产生积极的影响。因为人工智能算法可以分析大量的病人数据，包括医疗记录、实验室结果、成像扫描和遗传信息。通过处理这些数据，人工智能可以识别人类医生可能没有注意到的模式和细微指标，从而对心脏病发作进行更准确和可靠的诊断。

人工智能算法可以实时分析数据，提供快速和准确的心脏病发作诊断。这在时间紧迫的紧急情况下可能特别有用，使医生能够迅速开始适当的治疗。

Market Overview

The Global Heart Attack Diagnostics Market reached US$ 8,744.6 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 15,605.3 million by 2030. The global heart attack diagnostics market is expected to exhibit a CAGR of 7.7% during the forecast period (2023-2030).

The global heart attack diagnostics market is influenced by a number of variables, including dietary habits, environmental exposures, and genetic susceptibility. These elements can increase the risk of cardiovascular disease by causing high blood pressure, high cholesterol, obesity, and diabetes.

Heart attacks also are greatly influenced by unhealthy habits including smoking, drinking too much alcohol, and eating a lot of fast food. The prevalence of heart attacks among the population has increased as a result of the adoption of these harmful habits.

Market Dynamics

Adoption of Important Measures Used in New Product Launches

Heart attack diagnostics market expansion is being fueled by elements including rising healthcare spending, partnerships and collaborations between leading players, and increased R&D.

For instance, in November 2022, Heartbeat Health, the nation's largest virtual-first cardiovascular company, and Cleerly, the startup developing a new standard of care for heart illness, announced a partnership to employ precision heart health to more precisely evaluate cardiovascular risk and provide better heart care. Physicians may more quickly recognize, describe, and measure atherosclerosis (plaque buildup) in the walls of heart arteries thanks to Cleerly's AI-enabled approach for analyzing coronary computed tomography angiography (CCTA).

Additionally, in November 2022, CardioSignal and OMRON Healthcare, a manufacturing and sales of automation components, equipment and systems company, joined forces to serve doctors at the forefront of population health management by delivering breakthroughs in early cardiovascular disease detection to them.

The two businesses will work together to develop digital health solutions that enhance workflow procedures for lifestyle chronic diseases, particularly for the primary care identification of cardiovascular disease. Key players' strategies serve to propel the market in such a manner.

Lack of a Skilled Workforce will Hamper the Market Growth

A team of highly certified, skilled, and experienced healthcare experts is needed to carry out an efficient cardiac catheterization operation because it is a challenging treatment that demands a high level of precision and accuracy.

It is anticipated that throughout the projection period, market expansion will be somewhat constrained by a dearth of skilled specialists to perform coronary angiograms, particularly in emerging nations due to the absence of comprehensive training programs.

COVID-19 Impact Analysis

The SARS-CoV-2 virus epidemic led to a global lockdown and had a disastrous impact on heart attack diagnosis. People with heart conditions are more likely to develop the virus, especially those who are prone to heart attacks, and if the infection is not identified early enough, there is a high likelihood that they will die.

Additionally, there are significant worries regarding the long-term deterioration of cardiovascular health outcomes as a result of a lack of prompt diagnosis. There aren't many different parties involved in patient access to cardiovascular diagnosis and treatment.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine is estimated to have a minimal impact on the global heart attack diagnostics market owing to the absence of key market players in this region. However, the impact of the import and export of raw materials, test products, and devices is anticipated to have little influence over the global heart attack diagnostics market in the forecast period.

Artificial Intelligence Impact Analysis

Artificial intelligence is anticipated to impact the global heart attack diagnostics market positively. Because AI algorithms can analyze vast amounts of patient data, including medical records, lab results, imaging scans, and genetic information. By processing this data, AI can identify patterns and subtle indicators that may go unnoticed by human physicians, leading to more accurate and reliable diagnoses of heart attacks.

AI algorithms can analyze data in real-time, providing rapid and accurate diagnosis of heart attacks. This can be particularly useful in emergency situations where time is critical, allowing doctors to quickly begin appropriate treatment

Segment Analysis

The global heart attack diagnostics market is segmented based on test type, end-user, and region.

The Electrocardiogram Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period

The electrocardiogram segment holds about 47.5% of the total heart attack diagnostics market in the forecast period. ECG gathers crucial data on the general health and performance of the heart by measuring and documenting the electrical signals the heart produces as it contracts and relaxes. Additionally, the segment is growing as a result of the leading companies' product launches and technological improvements.

For instance, in September 2020, AliveCor, a personal electrocardiogram (ECG) technology business with US FDA clearance, made its entry into the Indian market with the release of KardiaMobile 6L, a clinically-validated personal ECG device. The personal ECG device is the only six-lead, FDA-approved personal ECG device available in the world. Atrial fibrillation (AFib), bradycardia, and tachycardia, the three most prevalent arrhythmias or abnormal heartbeats, can all be found using this device.

Geographical Analysis

Europe is Estimated To Hold the Second-largest Share Of The Global Heart Attack Diagnostics Market During The Forecast Period.

The Europe region holds the second largest share of the global heart attack diagnostics market accounting for approximately 32.1% in the forecast period.

Due to a constant increase in the number of patients with CAD and peripheral artery disorders, the market for global heart attack diagnostics is continuously witnessing growth. According to results made available by the European Union in March 2022, heart attacks were a significant cause of fatalities in the EU.

Additionally, technical developments are enabling portable characteristics in testing equipment, supporting the expansion of the market's revenue. In order to diagnose heart attacks and raise blood levels of MyC rather than troponin to rapidly rule out the possibility of heart attacks in patients, Kings College London created a novel blood test gadget.

Competitive Landscape

The major global players in the market include: F Hoffmann-La Roche Ltd, Hitachi Medical Systems, GE Healthcare, Schiller AG, Siemens Healthineers, HeartFlow, Beckman Coulter, Inc., Medtronic, Cardio Diagnostics Holdings Inc, and Midmark Corporation, among others.

Why Purchase the Report?

To visualize the global heart attack diagnostics market segmentation based on product, application, and region and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of heart attack diagnostics market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global heart attack diagnostics market report would provide approximately 53 tables,54 figures, and 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Test Type
3.2. Snippet by End User
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The high prevalence of cardiovascular diseases is expected to drive the market
  - 4.1.1.2. Technological advancements in heart attack diagnostics devices
- 4.1.2. Restraints
  - 4.1.2.1. Lack of skilled workforce will hamper the market growth
- 4.1.3. Opportunity
  - 4.1.3.1. The development of more sophisticated imaging techniques, such as cardiac MRI
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Epidemiology Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Impact Analysis

9. By Test Type

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 9.1.2. Market Attractiveness Index, By Test Type
9.2. Electrocardiogram
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Blood Tests
9.4. Angiogram
9.5. Computerized Cardiac Tomography
9.6. Magnetic Resonance Imaging (MRI)
9.7. Others

10. By End User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.1.2. Market Attractiveness Index, By End User
- 10.1.3. Hospitals
- 10.1.4. Introduction
- 10.1.5. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.2. Ambulatory Surgical Centers
10.3. Diagnostics Centers
10.4. Cardiac Centers
10.5. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.5.1. The U.S.
  - 11.2.5.2. Canada
  - 11.2.5.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.5.1. Germany
  - 11.3.5.2. The U.K.
  - 11.3.5.3. France
  - 11.3.5.4. Italy
  - 11.3.5.5. Spain
  - 11.3.5.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.5.1. Brazil
  - 11.4.5.2. Argentina
  - 11.4.5.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.5.1. China
  - 11.5.5.2. India
  - 11.5.5.3. Japan
  - 11.5.5.4. Australia
  - 11.5.5.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. F Hoffmann-La Roche Ltd
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Hitachi Medical Systems
13.3. GE Healthcare
13.4. Schiller AG
13.5. Siemens Healthineers
13.6. HeartFlow
13.7. Beckman Coulter, Inc.
13.8. Medtronic
13.9. Cardio Diagnostics Holdings Inc
13.10. Midmark Corporation.

LIST NOT EXHAUSTIVE

14. Appendix

14.1. About Us and Services
14.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球心脏病发作诊断市场 - 2023-2030年

Global Heart Attack Diagnostics Market - 2023-2030

市场概况

市场动态

采用新产品发布中使用的重要措施

缺少熟练的劳动力将阻碍市场的发展

COVID-19影响分析

俄乌战争影响分析

人工智能影响分析

目录

第一章：方法和范围

第二章：定义和概述

第三章：执行摘要

第四章：动态变化

第五章：行业分析

第六章：COVID-19分析

第7章 ：俄罗斯-乌克兰战争分析

第八章：人工智能影响分析

第九章：按测试类型

第十章：按终端用户分类

第十一章：按地区

第十二章 ：竞争格局

第十三章 ：公司简介

第十四章：附录